Related Experiment Video
Updated: Apr 9, 2026

07:08
Using Optical Coherence Tomography and Optokinetic Response As Structural and Functional Visual System Readouts in Mice and Rats
Published on: January 10, 2019
10.7K
OptiDON-Guard: An Ensemble Model for Identification of Dysthyroid Optic Neuropathy Using Optical Coherence Tomography
Yanchen Zhang1, Yicheng Mao1, Jianming Zheng2
1State Key Laboratory of Eye Health, Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China.
Translational Vision Science & Technology
|April 8, 2026
Summary
Machine learning models using optical coherence tomography angiography (OCTA) can effectively identify dysthyroid optic neuropathy (DON). The OptiDON-Guard model shows high accuracy and reliability in clinical settings.
Area of Science:
- Ophthalmology
- Medical Imaging
- Artificial Intelligence
Background:
- Dysthyroid optic neuropathy (DON) is a vision-threatening complication of thyroid eye disease.
- Accurate and early identification of DON is crucial for timely intervention.
Purpose of the Study:
- To evaluate the efficacy of machine learning models utilizing optical coherence tomography angiography (OCTA) for the diagnosis of DON.
- To develop and validate a robust diagnostic tool for DON.
Main Methods:
- A retrospective, dual-center study included 346 patients with thyroid eye disease.
- OCTA scans were analyzed using a two-tiered stacking ensemble model (OptiDON-Guard) with feature selection and pseudo-labeling.
- Model performance was assessed using AUC, accuracy, sensitivity, specificity, and precision on internal and external validation sets.
Main Results:
- The OptiDON-Guard ensemble model outperformed individual models.
- Internal validation: AUC of 0.872, accuracy 0.943, specificity 0.979.
- External validation: AUC of 0.854, accuracy 0.816, specificity 0.842.
Conclusions:
- OptiDON-Guard is a reliable, interpretable, and clinically applicable tool for DON identification.
- The model enhances diagnostic precision for DON, offering significant translational relevance.
Related Concept Videos
Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Glaucoma: Overview
1.7K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.7K
Angle Closure Glaucoma: Treatment
1.7K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.7K

